Mahesh Patel

Track

Insider profile

Currently holds a position at Lipocine Inc

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 59% 68% 82%
Transactions
26 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer Lipocine Inc Jan. 6, 2014 -
President, Chief Executive Officer, Director Lipocine Inc July 24, 2013 - Jan. 6, 2014
Mahesh Patel's trades of Lipocine Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
379.80
Quantity 95,442 +22.8%
Value US$261,163
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
12.37
Quantity 76,068 -19.5%
Value US$1,578,520
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
374.65
Quantity 34,787 +22.2%
Value US$1,745,750
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.32
Quantity 150,000 +9.8%
Value US$48,000
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.33
Quantity 50,000 +3.4%
Value US$16,500
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.39
Quantity 75,000 +5.3%
Value US$29,250
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.41
Quantity 100,000 +7.7%
Value US$41,000
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.77
Quantity 50,000 +4.0%
Value US$38,495
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
1.09
Quantity 25,000 +2.0%
Value US$27,250
US Lipocine Inc (LPCN)
Transaction date
Planned sale
Price
1.35
Quantity 15,000 -1.2%
Value US$20,250
US Lipocine Inc (LPCN)
Transaction date
Planned sale
Price
1.57
Quantity 43,500 -3.9%
Value US$68,134
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.38
Quantity 40,000 +4.3%
Value US$15,340
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.40
Quantity 25,000 +2.8%
Value US$9,975
US Lipocine Inc (LPCN)
Transaction date
Planned sale
Price
0.41
Quantity 43,500 -4.6%
Value US$17,835
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.43
Quantity 21,928 +2.8%
Value US$9,385
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.43
Quantity 1,100 +0.1%
Value US$470
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.43
Quantity 700 +0.1%
Value US$299
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.43
Quantity 1,272 +0.2%
Value US$543
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.42
Quantity 4,810 +0.6%
Value US$2,019
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.40
Quantity 40,259 +5.5%
Value US$16,104
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
0.40
Quantity 4,931 +0.7%
Value US$1,972
US Lipocine Inc (LPCN)
Transaction date
Planned sale
Price
3.48
Quantity 6,000 -0.8%
Value US$20,867
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
11.68
Quantity 1,300 +0.1%
Value US$15,179
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
11.68
Quantity 700 +0.1%
Value US$8,176
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
12.00
Quantity 2,000 +0.2%
Value US$24,000
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
5.10
Quantity 2,000 +0.2%
Value US$10,200
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
5.45
Quantity 2,000 +0.2%
Value US$10,900
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
5.06
Quantity 100 +0.0%
Value US$506
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
5.06
Quantity 1,900 +0.2%
Value US$9,614
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
5.05
Quantity 2,000 +0.2%
Value US$10,104
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-06 2026-04-06
US Lipocine Inc (LPCN)
B Purchase
95,442 +22.8%
379.80
US$261,163 		95,442 +22.8% 379.80 US$261,163
2026-04-02 2026-04-02
US Lipocine Inc (LPCN)
B Purchase
76,068 -19.5%
12.37
US$1,578,520 		76,068 -19.5% 12.37 US$1,578,520
2023-05-25 2023-05-25
US Lipocine Inc (LPCN)
B Purchase
34,787 +22.2%
374.65
US$1,745,750 		34,787 +22.2% 374.65 US$1,745,750
2023-03-24 2023-03-24
US Lipocine Inc (LPCN)
B Purchase
150,000 +9.8%
0.32
US$48,000 		150,000 +9.8% 0.32 US$48,000
2023-03-17 2023-03-17
US Lipocine Inc (LPCN)
B Purchase
50,000 +3.4%
0.33
US$16,500 		50,000 +3.4% 0.33 US$16,500
2022-11-14 2022-11-14
US Lipocine Inc (LPCN)
B Purchase
75,000 +5.3%
0.39
US$29,250 		75,000 +5.3% 0.39 US$29,250
2022-09-27 2022-09-27
US Lipocine Inc (LPCN)
B Purchase
100,000 +7.7%
0.41
US$41,000 		100,000 +7.7% 0.41 US$41,000
2022-05-16 2022-05-16
US Lipocine Inc (LPCN)
B Purchase
50,000 +4.0%
0.77
US$38,495 		50,000 +4.0% 0.77 US$38,495
2021-11-18 2021-11-18
US Lipocine Inc (LPCN)
B Purchase
25,000 +2.0%
1.09
US$27,250 		25,000 +2.0% 1.09 US$27,250
2020-12-17 2020-12-16
US Lipocine Inc (LPCN)
PlS Planned sale
15,000 -1.2%
1.35
US$20,250 		15,000 -1.2% 1.35 US$20,250
2020-12-08 2020-12-04
US Lipocine Inc (LPCN)
PlS Planned sale
43,500 -3.9%
1.57
US$68,134 		43,500 -3.9% 1.57 US$68,134
2020-01-02 2019-12-31
US Lipocine Inc (LPCN)
B Purchase
40,000 +4.3%
0.38
US$15,340 		40,000 +4.3% 0.38 US$15,340
2019-12-10 2019-12-10
US Lipocine Inc (LPCN)
B Purchase
25,000 +2.8%
0.40
US$9,975 		25,000 +2.8% 0.40 US$9,975
2019-12-06 2019-12-04
US Lipocine Inc (LPCN)
PlS Planned sale
43,500 -4.6%
0.41
US$17,835 		43,500 -4.6% 0.41 US$17,835
2019-11-26 2019-11-26
US Lipocine Inc (LPCN)
B Purchase
21,928 +2.8%
0.43
US$9,385 		21,928 +2.8% 0.43 US$9,385
2019-11-26 2019-11-26
US Lipocine Inc (LPCN)
B Purchase
1,100 +0.1%
0.43
US$470 		1,100 +0.1% 0.43 US$470
2019-11-26 2019-11-26
US Lipocine Inc (LPCN)
B Purchase
700 +0.1%
0.43
US$299 		700 +0.1% 0.43 US$299
2019-11-26 2019-11-26
US Lipocine Inc (LPCN)
B Purchase
1,272 +0.2%
0.43
US$543 		1,272 +0.2% 0.43 US$543
2019-11-18 2019-11-18
US Lipocine Inc (LPCN)
B Purchase
4,810 +0.6%
0.42
US$2,019 		4,810 +0.6% 0.42 US$2,019
2019-11-18 2019-11-18
US Lipocine Inc (LPCN)
B Purchase
40,259 +5.5%
0.40
US$16,104 		40,259 +5.5% 0.40 US$16,104
2019-11-18 2019-11-18
US Lipocine Inc (LPCN)
B Purchase
4,931 +0.7%
0.40
US$1,972 		4,931 +0.7% 0.40 US$1,972
2018-01-02 2017-12-29
US Lipocine Inc (LPCN)
PlS Planned sale
6,000 -0.8%
3.48
US$20,867 		6,000 -0.8% 3.48 US$20,867
2015-10-02 2015-09-30
US Lipocine Inc (LPCN)
B Purchase
1,300 +0.1%
11.68
US$15,179 		1,300 +0.1% 11.68 US$15,179
2015-10-02 2015-09-30
US Lipocine Inc (LPCN)
B Purchase
700 +0.1%
11.68
US$8,176 		700 +0.1% 11.68 US$8,176
2015-10-02 2015-09-30
US Lipocine Inc (LPCN)
B Purchase
2,000 +0.2%
12.00
US$24,000 		2,000 +0.2% 12.00 US$24,000
2014-11-25 2014-11-25
US Lipocine Inc (LPCN)
B Purchase
2,000 +0.2%
5.10
US$10,200 		2,000 +0.2% 5.10 US$10,200
2014-11-24 2014-11-24
US Lipocine Inc (LPCN)
B Purchase
2,000 +0.2%
5.45
US$10,900 		2,000 +0.2% 5.45 US$10,900
2014-11-14 2014-11-14
US Lipocine Inc (LPCN)
B Purchase
100 +0.0%
5.06
US$506 		100 +0.0% 5.06 US$506
2014-11-14 2014-11-14
US Lipocine Inc (LPCN)
B Purchase
1,900 +0.2%
5.06
US$9,614 		1,900 +0.2% 5.06 US$9,614
2014-11-13 2014-11-13
US Lipocine Inc (LPCN)
B Purchase
2,000 +0.2%
5.05
US$10,104 		2,000 +0.2% 5.05 US$10,104